Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes
- 8 February 2006
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 161 (1) , 61-72
- https://doi.org/10.1016/j.toxlet.2005.08.006
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon ReceptorPublished by Elsevier ,2005
- Aryl Hydrocarbon Receptor Activation and Cytochrome P450 1A Induction by the Mitogen-Activated Protein Kinase Inhibitor U0126 in HepatocytesMolecular Pharmacology, 2004
- Transcriptional Regulation of CYP2B1 Induction in Primary Rat Hepatocyte Cultures: Repression by Epidermal Growth Factor Is Mediated via a Distal Enhancer RegionMolecular Pharmacology, 2004
- Post‐transcriptional regulation of gene expression by mitogen‐activated protein kinase p38FEBS Letters, 2003
- Negative Feedback Regulation of MKK6 mRNA Stability by p38α Mitogen-Activated Protein KinaseMolecular and Cellular Biology, 2003
- Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytesBiochemical Pharmacology, 2002
- Cell cycle regulation by p38 MAP kinasesBiology of the Cell, 2001
- Gene Induction by Phenobarbital: An Update on an Old Question that Receives Key Novel AnswersBasic & Clinical Pharmacology & Toxicology, 2001
- The p38 MAP kinase inhibitor SB203580 enhances nuclear factor‐kappa B transcriptional activity by a non‐specific effect upon the ERK pathwayBritish Journal of Pharmacology, 2000
- Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CARJournal of Biological Chemistry, 1997